Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Arsenic Trioxide in Neuroblastoma and Other Pediatric Solid Tumors

NCT00024258 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.

NCT NCT00024258
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00024258 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Arsenic Trioxide in Neuroblastoma and Other Pediatric Solid Tumors
Lead sponsor
Memorial Sloan Kettering Cancer Center
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2001
Completion date
May 31, 2009
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain and central nervous system tumors, childhood germ cell tumor, extragonadal germ cell tumor, kidney cancer, liver cancer, neuroblastoma, ovarian cancer, retinoblastoma, sarcoma